Elicio Therapeutics, Inc. Balance Sheet
ELTX|2 years of annual SEC 10-K data (FY2021-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
Elicio Therapeutics, Inc. had $53M in total assets and $82M in shareholders' equity as of FY2022.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.36 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 |
|---|---|---|
| Cash & Equivalents | $50.5M | $88.8M |
| Current Assets | $51.4M | $91.2M |
| PP&E (Net) | $273.0K | $451.0K |
| Total Assets | $52.8M | $96.5M |
| Current Liabilities | $6.4M | $11.3M |
| Shareholders' Equity | $81.5M | -$90.4M |